HHLA2 Vs PD-L1 Expression in Urothelial Tumors

September 1, 2016
Alexander I. Sankin, MD

Alexander I. Sankin, MD, assistant professor of Urology at Montefiore Medical Center at the Albert Einstein College of Medicine, discusses the differences between the recently defined checkpoint HHLA2 and PD-L1 expression in urothelial tumors, as well as next steps in this space.